nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonorgestrel—CYP19A1—Paclitaxel—lung cancer	0.152	0.357	CbGbCtD
Levonorgestrel—CYP3A4—Topotecan—lung cancer	0.0389	0.0913	CbGbCtD
Levonorgestrel—CYP3A4—Gefitinib—lung cancer	0.0356	0.0835	CbGbCtD
Levonorgestrel—CYP3A4—Teniposide—lung cancer	0.0345	0.081	CbGbCtD
Levonorgestrel—CYP3A4—Vinorelbine—lung cancer	0.0274	0.0643	CbGbCtD
Levonorgestrel—CYP3A4—Crizotinib—lung cancer	0.0218	0.0512	CbGbCtD
Levonorgestrel—CYP3A4—Erlotinib—lung cancer	0.021	0.0494	CbGbCtD
Levonorgestrel—CYP3A4—Paclitaxel—lung cancer	0.0193	0.0452	CbGbCtD
Levonorgestrel—CYP3A4—Irinotecan—lung cancer	0.019	0.0446	CbGbCtD
Levonorgestrel—CYP3A4—Vinblastine—lung cancer	0.0169	0.0397	CbGbCtD
Levonorgestrel—CYP3A4—Etoposide—lung cancer	0.0152	0.0357	CbGbCtD
Levonorgestrel—CYP3A4—Docetaxel—lung cancer	0.0139	0.0327	CbGbCtD
Levonorgestrel—CYP3A4—Doxorubicin—lung cancer	0.0104	0.0244	CbGbCtD
Levonorgestrel—Hydrocortisone—ANXA1—lung cancer	0.00148	0.251	CrCbGaD
Levonorgestrel—Testosterone Propionate—UGT1A1—lung cancer	0.00128	0.218	CrCbGaD
Levonorgestrel—Hydrocortisone—ABCG2—lung cancer	0.000405	0.0689	CrCbGaD
Levonorgestrel—Progesterone—CYP2A6—lung cancer	0.000369	0.0628	CrCbGaD
Levonorgestrel—Testosterone—ABCG2—lung cancer	0.000312	0.0531	CrCbGaD
Levonorgestrel—Progesterone—CYP1A1—lung cancer	0.000258	0.044	CrCbGaD
Levonorgestrel—Norethindrone—ALB—lung cancer	0.000247	0.042	CrCbGaD
Levonorgestrel—Ethinyl Estradiol—ABCB1—lung cancer	0.000245	0.0417	CrCbGaD
Levonorgestrel—Testosterone—CYP1A1—lung cancer	0.000244	0.0416	CrCbGaD
Levonorgestrel—Norethindrone—ABCB1—lung cancer	0.000236	0.0401	CrCbGaD
Levonorgestrel—Methyltestosterone—ALB—lung cancer	0.000235	0.0399	CrCbGaD
Levonorgestrel—Infestation—Methotrexate—lung cancer	0.0002	0.000556	CcSEcCtD
Levonorgestrel—Infestation NOS—Methotrexate—lung cancer	0.0002	0.000556	CcSEcCtD
Levonorgestrel—Depression—Methotrexate—lung cancer	0.000199	0.000554	CcSEcCtD
Levonorgestrel—Anorexia—Paclitaxel—lung cancer	0.000199	0.000553	CcSEcCtD
Levonorgestrel—Pain—Cisplatin—lung cancer	0.000198	0.000552	CcSEcCtD
Levonorgestrel—Vomiting—Vinorelbine—lung cancer	0.000197	0.000548	CcSEcCtD
Levonorgestrel—Body temperature increased—Gemcitabine—lung cancer	0.000197	0.000548	CcSEcCtD
Levonorgestrel—Rash—Vinorelbine—lung cancer	0.000195	0.000544	CcSEcCtD
Levonorgestrel—Dermatitis—Vinorelbine—lung cancer	0.000195	0.000543	CcSEcCtD
Levonorgestrel—Abdominal distension—Doxorubicin—lung cancer	0.000195	0.000543	CcSEcCtD
Levonorgestrel—Headache—Vinorelbine—lung cancer	0.000194	0.00054	CcSEcCtD
Levonorgestrel—Syncope—Docetaxel—lung cancer	0.000194	0.00054	CcSEcCtD
Levonorgestrel—Asthma—Doxorubicin—lung cancer	0.000194	0.00054	CcSEcCtD
Levonorgestrel—Influenza—Doxorubicin—lung cancer	0.000194	0.00054	CcSEcCtD
Levonorgestrel—Palpitations—Docetaxel—lung cancer	0.000191	0.000532	CcSEcCtD
Levonorgestrel—Loss of consciousness—Docetaxel—lung cancer	0.00019	0.000529	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.00019	0.000528	CcSEcCtD
Levonorgestrel—Dyspnoea—Etoposide—lung cancer	0.00019	0.000527	CcSEcCtD
Levonorgestrel—Somnolence—Etoposide—lung cancer	0.000189	0.000526	CcSEcCtD
Levonorgestrel—Cough—Docetaxel—lung cancer	0.000189	0.000526	CcSEcCtD
Levonorgestrel—Insomnia—Paclitaxel—lung cancer	0.000189	0.000525	CcSEcCtD
Levonorgestrel—Hypersensitivity—Irinotecan—lung cancer	0.000188	0.000524	CcSEcCtD
Levonorgestrel—Hypertension—Docetaxel—lung cancer	0.000187	0.00052	CcSEcCtD
Levonorgestrel—Bronchitis—Doxorubicin—lung cancer	0.000187	0.000519	CcSEcCtD
Levonorgestrel—Dyspnoea—Paclitaxel—lung cancer	0.000186	0.000517	CcSEcCtD
Levonorgestrel—Somnolence—Paclitaxel—lung cancer	0.000185	0.000516	CcSEcCtD
Levonorgestrel—Decreased appetite—Etoposide—lung cancer	0.000185	0.000514	CcSEcCtD
Levonorgestrel—Chest pain—Docetaxel—lung cancer	0.000184	0.000513	CcSEcCtD
Levonorgestrel—Myalgia—Docetaxel—lung cancer	0.000184	0.000513	CcSEcCtD
Levonorgestrel—Nausea—Vinorelbine—lung cancer	0.000184	0.000512	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Etoposide—lung cancer	0.000184	0.000511	CcSEcCtD
Levonorgestrel—Dyspepsia—Paclitaxel—lung cancer	0.000184	0.000511	CcSEcCtD
Levonorgestrel—Body temperature increased—Cisplatin—lung cancer	0.000183	0.00051	CcSEcCtD
Levonorgestrel—Asthenia—Irinotecan—lung cancer	0.000183	0.00051	CcSEcCtD
Levonorgestrel—Fatigue—Etoposide—lung cancer	0.000183	0.00051	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000183	0.000509	CcSEcCtD
Levonorgestrel—Constipation—Etoposide—lung cancer	0.000182	0.000506	CcSEcCtD
Levonorgestrel—Pain—Etoposide—lung cancer	0.000182	0.000506	CcSEcCtD
Levonorgestrel—Dysuria—Doxorubicin—lung cancer	0.000181	0.000505	CcSEcCtD
Levonorgestrel—Decreased appetite—Paclitaxel—lung cancer	0.000181	0.000504	CcSEcCtD
Levonorgestrel—Upper respiratory tract infection—Doxorubicin—lung cancer	0.00018	0.000501	CcSEcCtD
Levonorgestrel—Haemoglobin—Methotrexate—lung cancer	0.00018	0.000501	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Paclitaxel—lung cancer	0.00018	0.000501	CcSEcCtD
Levonorgestrel—Fatigue—Paclitaxel—lung cancer	0.00018	0.0005	CcSEcCtD
Levonorgestrel—Haemorrhage—Methotrexate—lung cancer	0.000179	0.000499	CcSEcCtD
Levonorgestrel—Pollakiuria—Doxorubicin—lung cancer	0.000179	0.000498	CcSEcCtD
Levonorgestrel—Asthenia—Gemcitabine—lung cancer	0.000179	0.000497	CcSEcCtD
Levonorgestrel—Pain—Paclitaxel—lung cancer	0.000178	0.000496	CcSEcCtD
Levonorgestrel—Constipation—Paclitaxel—lung cancer	0.000178	0.000496	CcSEcCtD
Levonorgestrel—Pharyngitis—Methotrexate—lung cancer	0.000178	0.000495	CcSEcCtD
Levonorgestrel—Urinary tract disorder—Methotrexate—lung cancer	0.000177	0.000493	CcSEcCtD
Levonorgestrel—Oedema—Docetaxel—lung cancer	0.000177	0.000492	CcSEcCtD
Levonorgestrel—Weight increased—Doxorubicin—lung cancer	0.000177	0.000491	CcSEcCtD
Levonorgestrel—Pruritus—Gemcitabine—lung cancer	0.000176	0.00049	CcSEcCtD
Levonorgestrel—Urethral disorder—Methotrexate—lung cancer	0.000176	0.000489	CcSEcCtD
Levonorgestrel—Infection—Docetaxel—lung cancer	0.000176	0.000488	CcSEcCtD
Levonorgestrel—Weight decreased—Doxorubicin—lung cancer	0.000175	0.000488	CcSEcCtD
Levonorgestrel—Diarrhoea—Irinotecan—lung cancer	0.000175	0.000487	CcSEcCtD
Levonorgestrel—Pneumonia—Doxorubicin—lung cancer	0.000174	0.000484	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Etoposide—lung cancer	0.000174	0.000484	CcSEcCtD
Levonorgestrel—Shock—Docetaxel—lung cancer	0.000174	0.000484	CcSEcCtD
Levonorgestrel—Nervous system disorder—Docetaxel—lung cancer	0.000173	0.000482	CcSEcCtD
Levonorgestrel—Infestation NOS—Doxorubicin—lung cancer	0.000173	0.000481	CcSEcCtD
Levonorgestrel—Infestation—Doxorubicin—lung cancer	0.000173	0.000481	CcSEcCtD
Levonorgestrel—Visual impairment—Methotrexate—lung cancer	0.000173	0.000481	CcSEcCtD
Levonorgestrel—Skin disorder—Docetaxel—lung cancer	0.000172	0.000478	CcSEcCtD
Levonorgestrel—Hypersensitivity—Cisplatin—lung cancer	0.000171	0.000476	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Paclitaxel—lung cancer	0.00017	0.000474	CcSEcCtD
Levonorgestrel—Diarrhoea—Gemcitabine—lung cancer	0.00017	0.000474	CcSEcCtD
Levonorgestrel—Erythema multiforme—Methotrexate—lung cancer	0.00017	0.000472	CcSEcCtD
Levonorgestrel—Dizziness—Irinotecan—lung cancer	0.000169	0.00047	CcSEcCtD
Levonorgestrel—Urticaria—Etoposide—lung cancer	0.000169	0.00047	CcSEcCtD
Levonorgestrel—Hydrocortisone—ABCB1—lung cancer	0.000169	0.0287	CrCbGaD
Levonorgestrel—Anorexia—Docetaxel—lung cancer	0.000168	0.000469	CcSEcCtD
Levonorgestrel—Abdominal pain—Etoposide—lung cancer	0.000168	0.000468	CcSEcCtD
Levonorgestrel—Body temperature increased—Etoposide—lung cancer	0.000168	0.000468	CcSEcCtD
Levonorgestrel—Urinary tract infection—Doxorubicin—lung cancer	0.000168	0.000468	CcSEcCtD
Levonorgestrel—Eye disorder—Methotrexate—lung cancer	0.000168	0.000466	CcSEcCtD
Levonorgestrel—Asthenia—Cisplatin—lung cancer	0.000167	0.000463	CcSEcCtD
Levonorgestrel—Cardiac disorder—Methotrexate—lung cancer	0.000166	0.000463	CcSEcCtD
Levonorgestrel—Urticaria—Paclitaxel—lung cancer	0.000166	0.000461	CcSEcCtD
Levonorgestrel—Abdominal pain—Paclitaxel—lung cancer	0.000165	0.000459	CcSEcCtD
Levonorgestrel—Body temperature increased—Paclitaxel—lung cancer	0.000165	0.000459	CcSEcCtD
Levonorgestrel—Vomiting—Irinotecan—lung cancer	0.000163	0.000452	CcSEcCtD
Levonorgestrel—Sinusitis—Doxorubicin—lung cancer	0.000162	0.000451	CcSEcCtD
Levonorgestrel—Immune system disorder—Methotrexate—lung cancer	0.000162	0.000451	CcSEcCtD
Levonorgestrel—Mediastinal disorder—Methotrexate—lung cancer	0.000162	0.00045	CcSEcCtD
Levonorgestrel—Rash—Irinotecan—lung cancer	0.000161	0.000448	CcSEcCtD
Levonorgestrel—Dermatitis—Irinotecan—lung cancer	0.000161	0.000448	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000161	0.000448	CcSEcCtD
Levonorgestrel—Headache—Irinotecan—lung cancer	0.00016	0.000446	CcSEcCtD
Levonorgestrel—Insomnia—Docetaxel—lung cancer	0.00016	0.000445	CcSEcCtD
Levonorgestrel—Diarrhoea—Cisplatin—lung cancer	0.000159	0.000442	CcSEcCtD
Levonorgestrel—Alopecia—Methotrexate—lung cancer	0.000158	0.000441	CcSEcCtD
Levonorgestrel—Vomiting—Gemcitabine—lung cancer	0.000158	0.00044	CcSEcCtD
Levonorgestrel—Dyspnoea—Docetaxel—lung cancer	0.000158	0.000438	CcSEcCtD
Levonorgestrel—Somnolence—Docetaxel—lung cancer	0.000157	0.000437	CcSEcCtD
Levonorgestrel—Mental disorder—Methotrexate—lung cancer	0.000157	0.000437	CcSEcCtD
Levonorgestrel—Rash—Gemcitabine—lung cancer	0.000157	0.000437	CcSEcCtD
Levonorgestrel—Dermatitis—Gemcitabine—lung cancer	0.000157	0.000436	CcSEcCtD
Levonorgestrel—Hypersensitivity—Etoposide—lung cancer	0.000157	0.000436	CcSEcCtD
Levonorgestrel—Erythema—Methotrexate—lung cancer	0.000156	0.000434	CcSEcCtD
Levonorgestrel—Malnutrition—Methotrexate—lung cancer	0.000156	0.000434	CcSEcCtD
Levonorgestrel—Haemoglobin—Doxorubicin—lung cancer	0.000156	0.000434	CcSEcCtD
Levonorgestrel—Headache—Gemcitabine—lung cancer	0.000156	0.000434	CcSEcCtD
Levonorgestrel—Rhinitis—Doxorubicin—lung cancer	0.000156	0.000433	CcSEcCtD
Levonorgestrel—Dyspepsia—Docetaxel—lung cancer	0.000156	0.000433	CcSEcCtD
Levonorgestrel—Haemorrhage—Doxorubicin—lung cancer	0.000155	0.000432	CcSEcCtD
Levonorgestrel—Hypoaesthesia—Doxorubicin—lung cancer	0.000154	0.00043	CcSEcCtD
Levonorgestrel—Pharyngitis—Doxorubicin—lung cancer	0.000154	0.000429	CcSEcCtD
Levonorgestrel—Decreased appetite—Docetaxel—lung cancer	0.000154	0.000427	CcSEcCtD
Levonorgestrel—Hypersensitivity—Paclitaxel—lung cancer	0.000154	0.000427	CcSEcCtD
Levonorgestrel—Urinary tract disorder—Doxorubicin—lung cancer	0.000153	0.000427	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Docetaxel—lung cancer	0.000153	0.000424	CcSEcCtD
Levonorgestrel—Asthenia—Etoposide—lung cancer	0.000153	0.000424	CcSEcCtD
Levonorgestrel—Connective tissue disorder—Doxorubicin—lung cancer	0.000153	0.000424	CcSEcCtD
Levonorgestrel—Fatigue—Docetaxel—lung cancer	0.000152	0.000424	CcSEcCtD
Levonorgestrel—Urethral disorder—Doxorubicin—lung cancer	0.000152	0.000423	CcSEcCtD
Levonorgestrel—Nausea—Irinotecan—lung cancer	0.000152	0.000422	CcSEcCtD
Levonorgestrel—Pain—Docetaxel—lung cancer	0.000151	0.00042	CcSEcCtD
Levonorgestrel—Constipation—Docetaxel—lung cancer	0.000151	0.00042	CcSEcCtD
Levonorgestrel—Back pain—Methotrexate—lung cancer	0.000151	0.00042	CcSEcCtD
Levonorgestrel—Pruritus—Etoposide—lung cancer	0.00015	0.000419	CcSEcCtD
Levonorgestrel—Visual impairment—Doxorubicin—lung cancer	0.00015	0.000416	CcSEcCtD
Levonorgestrel—Asthenia—Paclitaxel—lung cancer	0.00015	0.000416	CcSEcCtD
Levonorgestrel—Nausea—Gemcitabine—lung cancer	0.000148	0.000412	CcSEcCtD
Levonorgestrel—Vomiting—Cisplatin—lung cancer	0.000148	0.000411	CcSEcCtD
Levonorgestrel—Pruritus—Paclitaxel—lung cancer	0.000148	0.00041	CcSEcCtD
Levonorgestrel—Erythema multiforme—Doxorubicin—lung cancer	0.000147	0.000408	CcSEcCtD
Levonorgestrel—Rash—Cisplatin—lung cancer	0.000146	0.000407	CcSEcCtD
Levonorgestrel—Dermatitis—Cisplatin—lung cancer	0.000146	0.000407	CcSEcCtD
Levonorgestrel—Diarrhoea—Etoposide—lung cancer	0.000145	0.000405	CcSEcCtD
Levonorgestrel—Eye disorder—Doxorubicin—lung cancer	0.000145	0.000404	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Docetaxel—lung cancer	0.000145	0.000402	CcSEcCtD
Levonorgestrel—Anaemia—Methotrexate—lung cancer	0.000144	0.000401	CcSEcCtD
Levonorgestrel—Cardiac disorder—Doxorubicin—lung cancer	0.000144	0.000401	CcSEcCtD
Levonorgestrel—Diarrhoea—Paclitaxel—lung cancer	0.000143	0.000397	CcSEcCtD
Levonorgestrel—Dizziness—Etoposide—lung cancer	0.000141	0.000391	CcSEcCtD
Levonorgestrel—Immune system disorder—Doxorubicin—lung cancer	0.00014	0.00039	CcSEcCtD
Levonorgestrel—Vertigo—Methotrexate—lung cancer	0.00014	0.00039	CcSEcCtD
Levonorgestrel—Mediastinal disorder—Doxorubicin—lung cancer	0.00014	0.000389	CcSEcCtD
Levonorgestrel—Abdominal pain—Docetaxel—lung cancer	0.00014	0.000389	CcSEcCtD
Levonorgestrel—Body temperature increased—Docetaxel—lung cancer	0.00014	0.000389	CcSEcCtD
Levonorgestrel—Arrhythmia—Doxorubicin—lung cancer	0.000139	0.000386	CcSEcCtD
Levonorgestrel—Dizziness—Paclitaxel—lung cancer	0.000138	0.000384	CcSEcCtD
Levonorgestrel—Nausea—Cisplatin—lung cancer	0.000138	0.000384	CcSEcCtD
Levonorgestrel—Progesterone—ABCB1—lung cancer	0.000137	0.0234	CrCbGaD
Levonorgestrel—Alopecia—Doxorubicin—lung cancer	0.000137	0.000382	CcSEcCtD
Levonorgestrel—Cough—Methotrexate—lung cancer	0.000136	0.000379	CcSEcCtD
Levonorgestrel—Testosterone—ALB—lung cancer	0.000136	0.0232	CrCbGaD
Levonorgestrel—Mental disorder—Doxorubicin—lung cancer	0.000136	0.000378	CcSEcCtD
Levonorgestrel—Vomiting—Etoposide—lung cancer	0.000135	0.000376	CcSEcCtD
Levonorgestrel—Erythema—Doxorubicin—lung cancer	0.000135	0.000376	CcSEcCtD
Levonorgestrel—Malnutrition—Doxorubicin—lung cancer	0.000135	0.000376	CcSEcCtD
Levonorgestrel—Rash—Etoposide—lung cancer	0.000134	0.000373	CcSEcCtD
Levonorgestrel—Dermatitis—Etoposide—lung cancer	0.000134	0.000373	CcSEcCtD
Levonorgestrel—Headache—Etoposide—lung cancer	0.000133	0.000371	CcSEcCtD
Levonorgestrel—Flatulence—Doxorubicin—lung cancer	0.000133	0.00037	CcSEcCtD
Levonorgestrel—Myalgia—Methotrexate—lung cancer	0.000133	0.00037	CcSEcCtD
Levonorgestrel—Chest pain—Methotrexate—lung cancer	0.000133	0.00037	CcSEcCtD
Levonorgestrel—Tension—Doxorubicin—lung cancer	0.000133	0.000369	CcSEcCtD
Levonorgestrel—Vomiting—Paclitaxel—lung cancer	0.000133	0.000369	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000132	0.000367	CcSEcCtD
Levonorgestrel—Rash—Paclitaxel—lung cancer	0.000131	0.000366	CcSEcCtD
Levonorgestrel—Dermatitis—Paclitaxel—lung cancer	0.000131	0.000365	CcSEcCtD
Levonorgestrel—Discomfort—Methotrexate—lung cancer	0.000131	0.000365	CcSEcCtD
Levonorgestrel—Nervousness—Doxorubicin—lung cancer	0.000131	0.000365	CcSEcCtD
Levonorgestrel—Back pain—Doxorubicin—lung cancer	0.000131	0.000364	CcSEcCtD
Levonorgestrel—Headache—Paclitaxel—lung cancer	0.000131	0.000363	CcSEcCtD
Levonorgestrel—Hypersensitivity—Docetaxel—lung cancer	0.00013	0.000362	CcSEcCtD
Levonorgestrel—Muscle spasms—Doxorubicin—lung cancer	0.00013	0.000361	CcSEcCtD
Levonorgestrel—Testosterone—ABCB1—lung cancer	0.00013	0.0221	CrCbGaD
Levonorgestrel—Asthenia—Docetaxel—lung cancer	0.000127	0.000353	CcSEcCtD
Levonorgestrel—Infection—Methotrexate—lung cancer	0.000127	0.000352	CcSEcCtD
Levonorgestrel—Nausea—Etoposide—lung cancer	0.000126	0.000351	CcSEcCtD
Levonorgestrel—Pruritus—Docetaxel—lung cancer	0.000125	0.000348	CcSEcCtD
Levonorgestrel—Nervous system disorder—Methotrexate—lung cancer	0.000125	0.000348	CcSEcCtD
Levonorgestrel—Anaemia—Doxorubicin—lung cancer	0.000125	0.000347	CcSEcCtD
Levonorgestrel—Nausea—Paclitaxel—lung cancer	0.000124	0.000345	CcSEcCtD
Levonorgestrel—Skin disorder—Methotrexate—lung cancer	0.000124	0.000344	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Methotrexate—lung cancer	0.000123	0.000343	CcSEcCtD
Levonorgestrel—Vertigo—Doxorubicin—lung cancer	0.000121	0.000338	CcSEcCtD
Levonorgestrel—Anorexia—Methotrexate—lung cancer	0.000121	0.000338	CcSEcCtD
Levonorgestrel—Syncope—Doxorubicin—lung cancer	0.000121	0.000337	CcSEcCtD
Levonorgestrel—Diarrhoea—Docetaxel—lung cancer	0.000121	0.000336	CcSEcCtD
Levonorgestrel—Palpitations—Doxorubicin—lung cancer	0.000119	0.000332	CcSEcCtD
Levonorgestrel—Loss of consciousness—Doxorubicin—lung cancer	0.000119	0.00033	CcSEcCtD
Levonorgestrel—Cough—Doxorubicin—lung cancer	0.000118	0.000328	CcSEcCtD
Levonorgestrel—Dizziness—Docetaxel—lung cancer	0.000117	0.000325	CcSEcCtD
Levonorgestrel—Hypertension—Doxorubicin—lung cancer	0.000117	0.000325	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000116	0.000323	CcSEcCtD
Levonorgestrel—Insomnia—Methotrexate—lung cancer	0.000115	0.00032	CcSEcCtD
Levonorgestrel—Chest pain—Doxorubicin—lung cancer	0.000115	0.00032	CcSEcCtD
Levonorgestrel—Myalgia—Doxorubicin—lung cancer	0.000115	0.00032	CcSEcCtD
Levonorgestrel—Anxiety—Doxorubicin—lung cancer	0.000115	0.000319	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000114	0.000318	CcSEcCtD
Levonorgestrel—Discomfort—Doxorubicin—lung cancer	0.000114	0.000316	CcSEcCtD
Levonorgestrel—Dyspnoea—Methotrexate—lung cancer	0.000114	0.000316	CcSEcCtD
Levonorgestrel—Somnolence—Methotrexate—lung cancer	0.000113	0.000315	CcSEcCtD
Levonorgestrel—Vomiting—Docetaxel—lung cancer	0.000112	0.000313	CcSEcCtD
Levonorgestrel—Dyspepsia—Methotrexate—lung cancer	0.000112	0.000312	CcSEcCtD
Levonorgestrel—Rash—Docetaxel—lung cancer	0.000111	0.00031	CcSEcCtD
Levonorgestrel—Dermatitis—Docetaxel—lung cancer	0.000111	0.00031	CcSEcCtD
Levonorgestrel—Decreased appetite—Methotrexate—lung cancer	0.000111	0.000308	CcSEcCtD
Levonorgestrel—Headache—Docetaxel—lung cancer	0.000111	0.000308	CcSEcCtD
Levonorgestrel—Oedema—Doxorubicin—lung cancer	0.00011	0.000307	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Methotrexate—lung cancer	0.00011	0.000306	CcSEcCtD
Levonorgestrel—Fatigue—Methotrexate—lung cancer	0.00011	0.000306	CcSEcCtD
Levonorgestrel—Infection—Doxorubicin—lung cancer	0.00011	0.000305	CcSEcCtD
Levonorgestrel—Pain—Methotrexate—lung cancer	0.000109	0.000303	CcSEcCtD
Levonorgestrel—Shock—Doxorubicin—lung cancer	0.000109	0.000302	CcSEcCtD
Levonorgestrel—Nervous system disorder—Doxorubicin—lung cancer	0.000108	0.000301	CcSEcCtD
Levonorgestrel—Skin disorder—Doxorubicin—lung cancer	0.000107	0.000298	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Doxorubicin—lung cancer	0.000107	0.000297	CcSEcCtD
Levonorgestrel—Anorexia—Doxorubicin—lung cancer	0.000105	0.000292	CcSEcCtD
Levonorgestrel—Nausea—Docetaxel—lung cancer	0.000105	0.000292	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Methotrexate—lung cancer	0.000104	0.00029	CcSEcCtD
Levonorgestrel—Urticaria—Methotrexate—lung cancer	0.000101	0.000282	CcSEcCtD
Levonorgestrel—Body temperature increased—Methotrexate—lung cancer	0.000101	0.00028	CcSEcCtD
Levonorgestrel—Abdominal pain—Methotrexate—lung cancer	0.000101	0.00028	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.0001	0.00028	CcSEcCtD
Levonorgestrel—Insomnia—Doxorubicin—lung cancer	9.98e-05	0.000278	CcSEcCtD
Levonorgestrel—Dyspnoea—Doxorubicin—lung cancer	9.83e-05	0.000274	CcSEcCtD
Levonorgestrel—Somnolence—Doxorubicin—lung cancer	9.8e-05	0.000273	CcSEcCtD
Levonorgestrel—Dyspepsia—Doxorubicin—lung cancer	9.71e-05	0.00027	CcSEcCtD
Levonorgestrel—Decreased appetite—Doxorubicin—lung cancer	9.59e-05	0.000267	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Doxorubicin—lung cancer	9.52e-05	0.000265	CcSEcCtD
Levonorgestrel—Fatigue—Doxorubicin—lung cancer	9.51e-05	0.000265	CcSEcCtD
Levonorgestrel—Pain—Doxorubicin—lung cancer	9.43e-05	0.000262	CcSEcCtD
Levonorgestrel—Constipation—Doxorubicin—lung cancer	9.43e-05	0.000262	CcSEcCtD
Levonorgestrel—Hypersensitivity—Methotrexate—lung cancer	9.38e-05	0.000261	CcSEcCtD
Levonorgestrel—Asthenia—Methotrexate—lung cancer	9.14e-05	0.000254	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Doxorubicin—lung cancer	9.02e-05	0.000251	CcSEcCtD
Levonorgestrel—Pruritus—Methotrexate—lung cancer	9.01e-05	0.000251	CcSEcCtD
Levonorgestrel—Urticaria—Doxorubicin—lung cancer	8.76e-05	0.000244	CcSEcCtD
Levonorgestrel—Abdominal pain—Doxorubicin—lung cancer	8.72e-05	0.000243	CcSEcCtD
Levonorgestrel—Body temperature increased—Doxorubicin—lung cancer	8.72e-05	0.000243	CcSEcCtD
Levonorgestrel—Diarrhoea—Methotrexate—lung cancer	8.71e-05	0.000242	CcSEcCtD
Levonorgestrel—Dizziness—Methotrexate—lung cancer	8.42e-05	0.000234	CcSEcCtD
Levonorgestrel—Hypersensitivity—Doxorubicin—lung cancer	8.13e-05	0.000226	CcSEcCtD
Levonorgestrel—Vomiting—Methotrexate—lung cancer	8.1e-05	0.000225	CcSEcCtD
Levonorgestrel—Rash—Methotrexate—lung cancer	8.03e-05	0.000223	CcSEcCtD
Levonorgestrel—Dermatitis—Methotrexate—lung cancer	8.02e-05	0.000223	CcSEcCtD
Levonorgestrel—Headache—Methotrexate—lung cancer	7.98e-05	0.000222	CcSEcCtD
Levonorgestrel—Asthenia—Doxorubicin—lung cancer	7.91e-05	0.00022	CcSEcCtD
Levonorgestrel—Pruritus—Doxorubicin—lung cancer	7.8e-05	0.000217	CcSEcCtD
Levonorgestrel—Nausea—Methotrexate—lung cancer	7.57e-05	0.00021	CcSEcCtD
Levonorgestrel—Diarrhoea—Doxorubicin—lung cancer	7.55e-05	0.00021	CcSEcCtD
Levonorgestrel—Dizziness—Doxorubicin—lung cancer	7.29e-05	0.000203	CcSEcCtD
Levonorgestrel—Vomiting—Doxorubicin—lung cancer	7.01e-05	0.000195	CcSEcCtD
Levonorgestrel—Rash—Doxorubicin—lung cancer	6.95e-05	0.000193	CcSEcCtD
Levonorgestrel—Dermatitis—Doxorubicin—lung cancer	6.95e-05	0.000193	CcSEcCtD
Levonorgestrel—Headache—Doxorubicin—lung cancer	6.91e-05	0.000192	CcSEcCtD
Levonorgestrel—Nausea—Doxorubicin—lung cancer	6.55e-05	0.000182	CcSEcCtD
Levonorgestrel—ESR1—Signaling by ERBB4—IL6—lung cancer	5.06e-05	0.000242	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	5.05e-05	0.000242	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ALDOA—lung cancer	4.98e-05	0.000239	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—APP—lung cancer	4.98e-05	0.000238	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NOTCH3—lung cancer	4.98e-05	0.000238	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—FGF9—lung cancer	4.93e-05	0.000236	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SKI—lung cancer	4.92e-05	0.000236	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—GSTM1—lung cancer	4.87e-05	0.000233	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—NCOA3—lung cancer	4.84e-05	0.000232	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	4.8e-05	0.00023	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	4.76e-05	0.000228	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	4.76e-05	0.000228	CbGpPWpGaD
Levonorgestrel—PGR—Generic Transcription Pathway—MYC—lung cancer	4.75e-05	0.000227	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—JUNB—lung cancer	4.71e-05	0.000226	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ADCY1—lung cancer	4.71e-05	0.000225	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ABCG2—lung cancer	4.71e-05	0.000225	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—CREBBP—lung cancer	4.7e-05	0.000225	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—AKT1—lung cancer	4.69e-05	0.000225	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—AKT1—lung cancer	4.67e-05	0.000224	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ENO2—lung cancer	4.62e-05	0.000221	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—HPGDS—lung cancer	4.62e-05	0.000221	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—CYP1A1—lung cancer	4.61e-05	0.000221	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	4.61e-05	0.000221	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PPP2R1B—lung cancer	4.59e-05	0.00022	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—PIK3CA—lung cancer	4.56e-05	0.000218	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	4.55e-05	0.000218	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—POMC—lung cancer	4.53e-05	0.000217	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—NOTCH3—lung cancer	4.49e-05	0.000215	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GSTT1—lung cancer	4.48e-05	0.000214	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GCLC—lung cancer	4.43e-05	0.000212	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CYP2A6—lung cancer	4.43e-05	0.000212	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	4.41e-05	0.000211	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—STK11—lung cancer	4.28e-05	0.000205	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PXN—lung cancer	4.28e-05	0.000205	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—JUNB—lung cancer	4.25e-05	0.000204	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ENO1—lung cancer	4.2e-05	0.000201	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—AKR1C1—lung cancer	4.19e-05	0.0002	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GRP—lung cancer	4.19e-05	0.0002	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—OXTR—lung cancer	4.19e-05	0.0002	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	4.18e-05	0.0002	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—FOXO3—lung cancer	4.13e-05	0.000198	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—ALB—lung cancer	4.13e-05	0.000198	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—COL4A3BP—lung cancer	4.06e-05	0.000194	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—AZIN2—lung cancer	4.06e-05	0.000194	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—ERCC2—lung cancer	4.01e-05	0.000192	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GNG11—lung cancer	3.92e-05	0.000188	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	3.89e-05	0.000186	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—AVP—lung cancer	3.87e-05	0.000185	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—CREBBP—lung cancer	3.85e-05	0.000184	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CYP2E1—lung cancer	3.76e-05	0.00018	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—VEGFC—lung cancer	3.73e-05	0.000179	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IGF1R—lung cancer	3.72e-05	0.000178	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—AKT1—lung cancer	3.72e-05	0.000178	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—NQO1—lung cancer	3.72e-05	0.000178	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—HES1—lung cancer	3.66e-05	0.000175	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	3.64e-05	0.000174	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—MYC—lung cancer	3.62e-05	0.000173	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	3.61e-05	0.000173	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ADCY1—lung cancer	3.52e-05	0.000169	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ATP5H—lung cancer	3.45e-05	0.000165	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—POMC—lung cancer	3.44e-05	0.000165	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PPP2R1B—lung cancer	3.43e-05	0.000164	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SMARCA4—lung cancer	3.43e-05	0.000164	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—STK11—lung cancer	3.35e-05	0.000161	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—ERBB3—lung cancer	3.34e-05	0.00016	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HSPB1—lung cancer	3.31e-05	0.000159	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PTHLH—lung cancer	3.28e-05	0.000157	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TERT—lung cancer	3.21e-05	0.000154	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.15e-05	0.000151	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—FGFR1—lung cancer	3.11e-05	0.000149	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GSTP1—lung cancer	3.1e-05	0.000149	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—ERCC2—lung cancer	3.09e-05	0.000148	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ANXA1—lung cancer	3.08e-05	0.000147	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PLBD1—lung cancer	3.08e-05	0.000147	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—HIF1A—lung cancer	3.07e-05	0.000147	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CAT—lung cancer	3.02e-05	0.000145	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—EP300—lung cancer	3e-05	0.000144	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—FLT1—lung cancer	2.98e-05	0.000143	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—APOA1—lung cancer	2.96e-05	0.000142	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ABCB1—lung cancer	2.94e-05	0.000141	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—CREBBP—lung cancer	2.93e-05	0.000141	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—KDR—lung cancer	2.93e-05	0.00014	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—APP—lung cancer	2.92e-05	0.00014	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NOTCH3—lung cancer	2.92e-05	0.00014	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—FGF9—lung cancer	2.9e-05	0.000139	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—TYMS—lung cancer	2.89e-05	0.000138	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GSTM1—lung cancer	2.85e-05	0.000137	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—HSD17B10—lung cancer	2.81e-05	0.000135	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—MYC—lung cancer	2.79e-05	0.000133	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—JUNB—lung cancer	2.77e-05	0.000132	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CYP1A1—lung cancer	2.7e-05	0.000129	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PIK3CG—lung cancer	2.7e-05	0.000129	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—KIT—lung cancer	2.7e-05	0.000129	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—APC—lung cancer	2.7e-05	0.000129	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ERCC2—lung cancer	2.68e-05	0.000128	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—EGF—lung cancer	2.67e-05	0.000128	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CKB—lung cancer	2.62e-05	0.000125	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—POMC—lung cancer	2.57e-05	0.000123	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—BRAF—lung cancer	2.54e-05	0.000122	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—STK11—lung cancer	2.51e-05	0.00012	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IL6R—lung cancer	2.51e-05	0.00012	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CREBBP—lung cancer	2.5e-05	0.00012	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CNDP2—lung cancer	2.46e-05	0.000118	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GSTM2—lung cancer	2.46e-05	0.000118	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—FOXO3—lung cancer	2.42e-05	0.000116	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—MTMR3—lung cancer	2.39e-05	0.000115	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MAP2K1—lung cancer	2.39e-05	0.000114	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PIK3CD—lung cancer	2.37e-05	0.000114	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—MAPK3—lung cancer	2.35e-05	0.000113	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PGAM1—lung cancer	2.33e-05	0.000112	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—APOA1—lung cancer	2.32e-05	0.000111	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—MYC—lung cancer	2.29e-05	0.000109	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—AVP—lung cancer	2.27e-05	0.000109	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—CREBBP—lung cancer	2.26e-05	0.000108	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CYP2A7—lung cancer	2.22e-05	0.000106	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.22e-05	0.000106	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IGF1R—lung cancer	2.19e-05	0.000105	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SDC4—lung cancer	2.18e-05	0.000104	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HES1—lung cancer	2.15e-05	0.000103	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MDM2—lung cancer	2.13e-05	0.000102	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—RAF1—lung cancer	2.12e-05	0.000102	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PIK3CG—lung cancer	2.12e-05	0.000101	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—ERBB2—lung cancer	2.1e-05	0.0001	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PIK3CB—lung cancer	2.07e-05	9.91e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MTOR—lung cancer	2.07e-05	9.91e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—POMC—lung cancer	2.02e-05	9.65e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CXCL8—lung cancer	1.99e-05	9.52e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—RRM1—lung cancer	1.98e-05	9.49e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GSTA3—lung cancer	1.98e-05	9.49e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CREBBP—lung cancer	1.96e-05	9.4e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ERBB3—lung cancer	1.96e-05	9.4e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CASP3—lung cancer	1.9e-05	9.12e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IL2—lung cancer	1.9e-05	9.1e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TERT—lung cancer	1.88e-05	9.01e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—B4GALT5—lung cancer	1.86e-05	8.92e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PIK3CD—lung cancer	1.86e-05	8.91e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CCND1—lung cancer	1.85e-05	8.87e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—JUN—lung cancer	1.85e-05	8.85e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ALB—lung cancer	1.84e-05	8.8e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—FGFR1—lung cancer	1.83e-05	8.75e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GSTA4—lung cancer	1.81e-05	8.68e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HIF1A—lung cancer	1.8e-05	8.62e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MMP9—lung cancer	1.8e-05	8.61e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CDKN1A—lung cancer	1.79e-05	8.58e-05	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—MAPK3—lung cancer	1.79e-05	8.57e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PTEN—lung cancer	1.79e-05	8.56e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GSTA2—lung cancer	1.77e-05	8.46e-05	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—MYC—lung cancer	1.74e-05	8.34e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—APOA1—lung cancer	1.74e-05	8.31e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—KDR—lung cancer	1.72e-05	8.24e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—EP300—lung cancer	1.71e-05	8.17e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GSTA1—lung cancer	1.7e-05	8.16e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ABCC3—lung cancer	1.69e-05	8.07e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—SRC—lung cancer	1.66e-05	7.94e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—AKR1C1—lung cancer	1.63e-05	7.81e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PIK3CB—lung cancer	1.62e-05	7.77e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—VEGFA—lung cancer	1.62e-05	7.74e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PTGS2—lung cancer	1.61e-05	7.7e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—STAT3—lung cancer	1.6e-05	7.66e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NRAS—lung cancer	1.6e-05	7.64e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—KIT—lung cancer	1.59e-05	7.59e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—APC—lung cancer	1.59e-05	7.59e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PIK3CG—lung cancer	1.59e-05	7.59e-05	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—AKT1—lung cancer	1.59e-05	7.59e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—UGT1A1—lung cancer	1.58e-05	7.59e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—EGF—lung cancer	1.57e-05	7.5e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MAPK3—lung cancer	1.53e-05	7.32e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GNG11—lung cancer	1.53e-05	7.32e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—POMC—lung cancer	1.51e-05	7.23e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—BRAF—lung cancer	1.49e-05	7.14e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MYC—lung cancer	1.49e-05	7.12e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IL6R—lung cancer	1.47e-05	7.05e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CREBBP—lung cancer	1.47e-05	7.04e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ALDOA—lung cancer	1.45e-05	6.97e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—EGFR—lung cancer	1.45e-05	6.96e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—NCOA3—lung cancer	1.41e-05	6.76e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MAP2K1—lung cancer	1.4e-05	6.72e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PTEN—lung cancer	1.4e-05	6.71e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PIK3CD—lung cancer	1.39e-05	6.67e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—MAPK3—lung cancer	1.38e-05	6.61e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ADCY1—lung cancer	1.37e-05	6.58e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ABCG2—lung cancer	1.37e-05	6.58e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—KRAS—lung cancer	1.37e-05	6.58e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ENO2—lung cancer	1.35e-05	6.45e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—HPGDS—lung cancer	1.35e-05	6.45e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—MYC—lung cancer	1.34e-05	6.42e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.34e-05	6.41e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—EP300—lung cancer	1.34e-05	6.4e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GSTT1—lung cancer	1.31e-05	6.26e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GCLC—lung cancer	1.29e-05	6.18e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CYP2A6—lung cancer	1.29e-05	6.18e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PIK3CA—lung cancer	1.26e-05	6.04e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MDM2—lung cancer	1.25e-05	5.98e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—RAF1—lung cancer	1.24e-05	5.96e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ERBB2—lung cancer	1.23e-05	5.89e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ENO1—lung cancer	1.22e-05	5.86e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TP53—lung cancer	1.22e-05	5.84e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MTOR—lung cancer	1.21e-05	5.82e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PIK3CB—lung cancer	1.21e-05	5.82e-05	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—AKT1—lung cancer	1.21e-05	5.78e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CXCL8—lung cancer	1.17e-05	5.59e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—HRAS—lung cancer	1.17e-05	5.59e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CASP3—lung cancer	1.12e-05	5.35e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IL6—lung cancer	1.12e-05	5.35e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IL2—lung cancer	1.12e-05	5.34e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CYP2E1—lung cancer	1.1e-05	5.26e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CCND1—lung cancer	1.09e-05	5.21e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—NQO1—lung cancer	1.09e-05	5.2e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—JUN—lung cancer	1.09e-05	5.2e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MMP9—lung cancer	1.06e-05	5.06e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CDKN1A—lung cancer	1.05e-05	5.04e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PTEN—lung cancer	1.05e-05	5.03e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—AKT1—lung cancer	1.03e-05	4.94e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—EP300—lung cancer	1e-05	4.79e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PIK3CA—lung cancer	9.89e-06	4.74e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—STK11—lung cancer	9.79e-06	4.69e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SRC—lung cancer	9.73e-06	4.66e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—VEGFA—lung cancer	9.48e-06	4.54e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—STAT3—lung cancer	9.39e-06	4.5e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NRAS—lung cancer	9.36e-06	4.48e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—AKT1—lung cancer	9.3e-06	4.46e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GSTP1—lung cancer	9.06e-06	4.34e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MAPK3—lung cancer	8.97e-06	4.29e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CAT—lung cancer	8.81e-06	4.22e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MYC—lung cancer	8.72e-06	4.18e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ABCB1—lung cancer	8.57e-06	4.11e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—EGFR—lung cancer	8.53e-06	4.09e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—TYMS—lung cancer	8.42e-06	4.03e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GSTM1—lung cancer	8.32e-06	3.99e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—AKT1—lung cancer	8.08e-06	3.87e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—KRAS—lung cancer	8.06e-06	3.86e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CYP1A1—lung cancer	7.89e-06	3.78e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ERCC2—lung cancer	7.83e-06	3.75e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PIK3CA—lung cancer	7.4e-06	3.55e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TP53—lung cancer	7.16e-06	3.43e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HRAS—lung cancer	6.85e-06	3.28e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—APOA1—lung cancer	6.77e-06	3.24e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IL6—lung cancer	6.56e-06	3.14e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PIK3CG—lung cancer	6.18e-06	2.96e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—AKT1—lung cancer	6.05e-06	2.9e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—POMC—lung cancer	5.88e-06	2.82e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CREBBP—lung cancer	5.73e-06	2.74e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PIK3CD—lung cancer	5.43e-06	2.6e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ALB—lung cancer	5.36e-06	2.57e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PIK3CB—lung cancer	4.74e-06	2.27e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PTGS2—lung cancer	4.69e-06	2.25e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PTEN—lung cancer	4.09e-06	1.96e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—EP300—lung cancer	3.9e-06	1.87e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PIK3CA—lung cancer	2.89e-06	1.38e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—AKT1—lung cancer	2.36e-06	1.13e-05	CbGpPWpGaD
